|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
130,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,187 |
| Total Buy Value |
$0 |
$0 |
$0 |
$38,963 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
260,206 |
264,154 |
284,904 |
293,229 |
| Total Sell Value |
$12,881,642 |
$13,052,007 |
$13,677,087 |
$13,910,122 |
| Total People Sold |
6 |
6 |
6 |
6 |
| Total Sell Transactions |
14 |
19 |
25 |
31 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Potter Myrtle S |
Director |
– • – |
2025-06-18 |
4 |
S |
$49.47 |
$1,286 |
D/D |
(26) |
18,154 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-06-18 |
4 |
S |
$49.47 |
$158,947 |
D/D |
(3,213) |
7,190 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2025-06-17 |
4 |
S |
$48.38 |
$322,819 |
I/I |
(6,672) |
9,851 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-06-16 |
4 |
S |
$49.70 |
$130,512 |
D/D |
(2,626) |
18,180 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
10,403 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2025-06-15 |
4 |
D |
$49.29 |
$11,238 |
D/D |
(228) |
19,174 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
637 |
19,402 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2025-06-15 |
4 |
D |
$49.29 |
$81,772 |
D/D |
(1,659) |
42,001 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,272 |
43,660 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2025-06-15 |
4 |
D |
$49.29 |
$26,370 |
D/D |
(535) |
43,568 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,020 |
44,103 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-06-15 |
4 |
D |
$49.29 |
$131,851 |
D/D |
(2,675) |
46,757 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,281 |
49,432 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
20,806 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-06-15 |
4 |
D |
$49.29 |
$35,045 |
D/D |
(711) |
35,124 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,402 |
35,835 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2025-06-13 |
4 |
S |
$47.22 |
$157,573 |
D/D |
(3,337) |
11,150 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,674 |
10,153 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,674 |
17,665 |
|
- |
|
| Gadde Vijaya |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,674 |
24,314 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
I/I |
8,088 |
16,523 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,674 |
20,737 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2025-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,674 |
14,487 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-06-09 |
4 |
AS |
$50.09 |
$3,899,937 |
D/D |
(77,853) |
2,069,456 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-06-06 |
4 |
AS |
$50.07 |
$1,990,420 |
D/D |
(39,751) |
2,147,309 |
|
- |
|
951 Records found
|
|
Page 1 of 39 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
